Brief: Mustang Bio Reports Third Quarter 2022 Financial Results
14/11/2022 21:24
Nov 14 (Reuters) - Mustang Bio Inc MBIO.O :
* QTRLY LOSS PER SHARE $0.18
* Q3 EARNINGS PER SHARE VIEW $-0.20 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX4sVlCd
Further company coverage: MBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mustang Bio
See all newsAdvisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
U.S. STOCKS ON THE MOVE-Dow, Phibro, Mustang Bio
Mustang soars on FDA's orphan drug tag for brain cancer therapy
Mustang Bio Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Mustang Bio Inc - Enters Sale And Surrender Agreement With Abbvie